Effect of Intracervical on the Pain Associated With the Insertion of the LNG-IUS

• Status: Completed
• Trial end date: 2013-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study has the objective to evaluate the effect of Injectable intracervical anesthesia in comparison with a non-steroidal anti-inflammatory drug (NSAID) on the pain scores immediately after insertion of the levonorgestrel-releasing intrauterine system (LNG-IUS) in women without previous vaginal delivery.

H0: There is no difference in terms of pain score between the treatments H1: There will be difference in terms of pain score between treatments

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Sao Paulo
• Collaborator: Conselho Nacional de Desenvolvimento Científico e Tecnológico
• Treatments: Anesthetics; Ibuprofen; Levonorgestrel; Lidocaine

Criteria

Inclusion Criteria:

• patients who wanted to use the LNG-IUS as a contraceptive

• age between 18 and 45 years

• nulliparity

• absence of previous vaginal delivery

Exclusion Criteria:

• women in categories 3 and/or 4 for LNG-IUS use according to the medical eligibility criteria of the World Health Organization

• illicit drug and/or alcohol users

• women with allergies or contraindications to NSAIDs or lidocaine

• chronic pelvic pain of any etiology

• abnormalities in the cervix (such as fibrosis or isthmus-cervical incompetence)

• previous abortion with or without uterine curettage

• psychiatric disorders

• continued use of medications that could interfere with the pain threshold